treprostinil

Key facts

INN

treprostinil

Brand

TREPROSTINIL

Route

INHALATION

Formulation

INJECTABLE

Originator

UNITED THERAPEUTICS Corp

Related patents

patent

US 12357599

Prodrugs of treprostinil

Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12173021

Treprostinil prodrugs

Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12168071

Treprostinil derivatives and their use in pharmaceutical compositions

Expires Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11826328

Stable treprostinil prodrugs

Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11723887

Process to prepare treprostinil, the active ingredient in Remodulin®

Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11672775

Treprostinil prodrugs

Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11634443

Treprostinil prodrugs

Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11571444

Enhancement of MSC immunomodulatory properties by treprostinil

Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is treprostinil?

treprostinil (TREPROSTINIL), is a pharmaceutical active ingredient, associated with UNITED THERAPEUTICS Corp, with approved status in the US.

What is the brand name for treprostinil?

TREPROSTINIL is a marketed brand name for treprostinil. Check FDA Drugs@FDA for the current US label holder.